Article
Gallium compound GaQ 3 ‐induced Ca 2+ signalling triggers p53‐dependent and ‐independent apoptosis in cancer cells
10 Nov 2011
Abstract excerpt
BACKGROUND AND PURPOSE A novel anti-neoplastic gallium complex GaQ(3) (KP46), earlier developed by us, is currently in phase I clinical trial. GaQ(3) induced S-phase arrest and apoptosis via caspase/PARP cleavage in a variety of cancers. However, the underlying mechanism of apoptosis is unknown. Here, we have explored the mechanism(s) of GaQ(3) -induced apoptosis in cancer cells, focusing on p53 and intracellular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
